Chemours
435 hedge funds and large institutions have $2.64B invested in Chemours in 2024 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 113 increasing their positions, 125 reducing their positions, and 63 closing their positions.
1% more ownership
Funds ownership: 77.51% → 78.51% (+1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 63
4% less call options, than puts
Call options by funds: $33.1M | Put options by funds: $34.6M
10% less repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 125
2% less funds holding
Funds holding: 443 → 435 (-8)
13% less capital invested
Capital invested by funds: $3.02B → $2.64B (-$384M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$35.3M |
| 2 |
KCM
Khrom Capital Management
Miami Beach,
Florida
|
+$32M |
| 3 |
LM
Luminus Management
Houston,
Texas
|
+$18.3M |
| 4 |
Two Sigma Investments
New York
|
+$18.2M |
| 5 |
FACM
Forest Avenue Capital Management
Miami,
Florida
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$53M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$21.4M |
| 3 |
Millennium Management
New York
|
-$13.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11M |
| 5 |
AWAM
Appian Way Asset Management
New York
|
-$7.58M |
CC Hedge Fund Activity: Q2 2024 in Review
435 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2024, worth a combined $2.64B — down 13% from $3.02B a quarter earlier.
Sellers outnumbered buyers: 63 funds closed out of CC and 62 opened new positions — a net loss of 1 holder — while 125 trimmed existing stakes and 113 added.
The largest buyer was Marshall Wace, adding an estimated $35.3M. The largest seller was Fidelity Investments, cutting an estimated $53M.
- 435 institutional investors held Chemours (CC) as of Q2 2024, down from 443 in Q1 2024.
- Funds reported $2.64B of Chemours stock for Q2 2024, down 13% quarter-over-quarter.
- 62 funds opened new Chemours positions in Q2 2024 and 63 closed out, a net change of -1 holder.
- The largest Chemours buyer in Q2 2024 was Marshall Wace, an estimated $35.3M added.
- The largest Chemours seller in Q2 2024 was Fidelity Investments, an estimated $53M sold.
Based on aggregated 13F filings for Q2 2024.